Literature DB >> 32693380

Seizure occurrence and related mortality in dementia with Lewy bodies.

Rohit Marawar1, Nicole Wakim2, Roger L Albin3, Hiroko Dodge4.   

Abstract

Dementia is a risk factor for epilepsy. While seizures have a well-established association with Alzheimer's disease (AD), their association with dementia with Lewy bodies (DLB) is not established. We utilized the National Alzheimer's Coordinating Centers' Uniform Data Set (NACC-UDS V1-3) to analyze occurrence of seizures in DLB and seizure occurrence associations with mortality. We excluded subjects with conventional seizure risk factors. Seizure occurrence was noted in 36 subjects (2.62%) out of 1376 subjects with DLB. Among 500 subjects with pathologically confirmed DLB, seizure occurrence was documented in 19 (3.8%) subjects. Half of the subjects had onset of seizures three years before or after DLB diagnosis. Two-year mortality for subjects with DLB with seizures was high at 52.8% but no increased risk was noted as compared with subjects with DLB without seizures. More prospective and long-term longitudinal studies are needed to clarify relationships between DLB, seizure occurrence, and risk of increased mortality.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dementia with Lewy bodies; Epilepsy; Mortality; NACC; Seizures

Year:  2020        PMID: 32693380      PMCID: PMC7541707          DOI: 10.1016/j.yebeh.2020.107311

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  2 in total

1.  Treatment of Seizures in Older Patients with Dementia.

Authors:  Benjamin Cretin
Journal:  Drugs Aging       Date:  2020-12-14       Impact factor: 3.923

2.  Prodromal Dementia With Lewy Bodies and Recurrent Panic Attacks as the First Symptom: A Case Report.

Authors:  Alberto Jaramillo-Jimenez; Yinbing Ying; Ping Ren; Zhan Xiao; Qian Zhang; Jian Wang; Han Rong; Miguel Germán Borda; Laura Bonanni; Dag Aarsland; Donghui Wu
Journal:  Front Neurol       Date:  2022-04-13       Impact factor: 4.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.